000 01429 a2200337 4500
005 20250517084504.0
264 0 _c20170214
008 201702s 0 0 eng d
022 _a2171-8695
024 7 _a10.7399/fh.2016.40.2.9233
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLeganés-Ramos, Alejandro
245 0 0 _aOral formulation of pyridoxine for the treatment of pyridoxinedependent epilepsy in a paediatric patient.
_h[electronic resource]
260 _bFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_cMar 2016
300 _a131-3 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aDrug Compounding
650 0 4 _aEpilepsy
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHyperlysinemias
_xdrug therapy
650 0 4 _aInfant, Newborn
650 0 4 _aPipecolic Acids
_xblood
650 0 4 _aPyridoxine
_xadministration & dosage
650 0 4 _aVitamin B Complex
_xadministration & dosage
700 1 _aÁlvaro-Alonso, Elena Alba
700 1 _aMartín de Rosales-Cabrera, Ana María
700 1 _aPérez-Encinas, Montserrat
773 0 _tFarmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria
_gvol. 40
_gno. 2
_gp. 131-3
856 4 0 _uhttps://doi.org/10.7399/fh.2016.40.2.9233
_zAvailable from publisher's website
999 _c25830536
_d25830536